Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 15874101000001118 | Cytarabine 50mg/5ml intrathecal suspension for injection vials (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 15874201000001113 | Cytarabine 50mg/5ml intrathecal suspension for injection vials | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 37680701000001112 | Cytarabine 50mg/5ml suspension for injection vials | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 42370501000001115 | Cytarabine (liposomal) 50mg/5ml suspension for injection vials | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) | Is a | True | Cytarabine 50mg/5ml intrathecal suspension for injection vials | Inferred relationship | Existential restriction modifier | |
| Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial | Is pack of | False | Cytarabine 50mg/5ml intrathecal suspension for injection vials | Inferred relationship | Existential restriction modifier | |
| Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial | Has VMP | True | Cytarabine 50mg/5ml intrathecal suspension for injection vials | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets